Skip to main content
. Author manuscript; available in PMC: 2015 May 7.
Published in final edited form as: JAMA Intern Med. 2014 Mar;174(3):324–333. doi: 10.1001/jamainternmed.2013.13656

Figure 3. 40-Month Decline in Total Brain Volume (TBV) in the Blood Pressure (BP) and Lipid Trials.

Figure 3

Whiskers mark 95% confidence intervals. Intensive and standard glycemia therapy groups are described in the Supplement (eAppendix). Standard and intensive BP interventions and active and placebo lipid treatments are described in the legend to Figure 1.

aP < .001 for heterogeneity of glycemia effect.

bP = .86 for heterogeneity of glycemia effect.